Simply Wall St.
How Recent Developments Are Shaping the Investment Story for Privia Health
📊
AI Sentiment
Positive
7/10
- Home
- PRVA
as of 12-04-2025 3:41pm EST
$23.90
$0.40
-1.65%
Privia Health Group Inc is a technology-driven, national physician-enablement company. It collaborates with medical groups, health plans, and health systems to optimize physician practices, improve patient experiences, and reward doctors for delivering high-value care in both in-person and virtual care settings.
Chart Type:
Time Range:
| Founded: | 2007 | Country: | United States |
| Employees: | N/A | City: | ARLINGTON |
| Market Cap: | 3.1B | IPO Year: | 2021 |
| Target Price: | $30.07 | AVG Volume (30 days): | 776.8K |
| Analyst Decision: | Strong Buy | Number of Analysts: | 14 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | 0.14 | EPS Growth: | 29.88 |
| 52 Week Low/High: | $18.77 - $26.51 | Next Earning Date: | 11-06-2025 |
| Revenue: | $2,042,569,000 | Revenue Growth: | 19.01% |
| Revenue Growth (this year): | 103.35% | Revenue Growth (next year): | 9.63% |
AI-Powered PRVA Daily Prediction
Machine learning model trained on 25+ technical indicators
Updated 2 days ago
AI Recommendation
hold
Model Accuracy: 75.50%
75.50%
Confidence
Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.
Latest Privia Health Group Inc. News
PRVA Breaking Stock News: Dive into PRVA Ticker-Specific Updates for Smart Investing
Simply Wall St.
A Look at Privia Health Group’s (PRVA) Valuation Following Strong Q3 Results and Cautious Guidance
📊
AI Sentiment
Positive
7/10
Compare PRVA vs Leading Stocks
See how PRVA stacks up against similar companies in the market
Head-to-Head Comparisons
Share on Social Networks:
Tools & Resources
Enhance your trading experience with our free tools
Disclaimer
The information presented on this page, "PRVA Privia Health Group Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.